<DOC>
	<DOCNO>NCT01818700</DOCNO>
	<brief_summary>The purpose study ass pain reduction rate 8 week treatment NORSPAN® baseline . And secondary purpose : pain reduction rate 4 week treatment baseline ( week 0 ) EQ-5D , pain sleep questionnaire , physician 's overall satisfaction subject 's overall satisfaction , safety</brief_summary>
	<brief_title>An Interventional Study Assess Efficacy Safety Buprenorphine Korean Patients With Spinal Disorders</brief_title>
	<detailed_description>Upon provide write informed consent , subject screen study assessment perform time safety laboratory assessment , physical examination , vital sign , medical history taking , 24 hour pain intensity score , EQ-5D , pain sleep questionnaire , physician 's overall satisfaction subject 's overall satisfaction . If patient eligible inclusion/exclusion criterion time visit 1 , patient receive treatment NORSPAN® . Treatment NORSPAN® start 5 μg/h ( 1 patch week ) 2 week , proper titration ( up-titration ) allow visit 2 ( wk 2 ) visit 3 ( wk 4 ) accord investigator 's decision .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Spinal Diseases</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>20 year old male female Korean patient Patients spinal disorder related pain Patients treat weak opioids and/or NSAIDs study participation Patients moderate severe pain intensity Naïve patient Buprenorphine ( Naïve patient define treated Buprenorphine 90 day ) Patients sign write informed consent form Women childbearing potential , defined woman physiologically capable become pregnant . UNLESS : woman whose partner sterilize vasectomy mean use two birth control method . The two method double barrier method barrier method plus hormonal method . Adequate barrier method contraception include : diaphragm , condom ( partner ) , intrauterine device ( copper hormonal ) , sponge spermicide . Hormonal contraceptive include market contraceptive agent include estrogen and/or progestational agent . Pregnant nursing ( lactate ) woman , pregnancy define state female conception termination gestation , confirm positive urine pregnancy test Patients know hypersensitivity buprenorphine excipients Patients severely impaired respiratory function respiratory depression status Patients concurrently receive MAOIs receive MAOIs within previous two week Patients convulsive disorder , head injury , shock , reduce level consciousness uncertain origin , intracranial lesion increase intracranial pressure , patient severe hepatic impairment Patients biliary tract disorder Patients know , suspected history drug abuse Patients history opioid drug dependence Patients concurrently take CNS depressant muscle relaxant may cause respiratory depression , hypotension , profound sedation potentially result coma . Patients take Buprenorphine strong opioid . Any situation Buprenorphine contraindicate Major surgery within 1 month prior screen plan surgery Mainly pain originated spinal disorder disease Nonmalignant patient cancer patient receive oncology treatment could affect measure pain control With disability may prevent patient complete study requirement particular , interfere 24hrs pain intensity score Clinically significant impairment cardiovascular , respiratory renal function Patient need acute dose titration whose pain intensity fluctuate significantly short period accord investigator 's judgment Having use investigational drug time enrollment , within 30 day enrollment</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>